International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.08 and traded as high as ...

STEM Potential supports you through years 10 and 12 with insightful lectures, subject-specific workshops and a non-residential summer school. STEM Potential is a multi-year programme of activities and ...

They found that the treatment reversed brain hyperexcitability in rats with strokes, restoring balance in neural networks ... even in the chronic phase after a stroke.” The scientists also analyzed ...

In the new study, Paz and her collaborators tested a stem cell therapy under development by SanBio. One month after rats had a stroke, the scientists injected the modified human ... reversed brain ...

Scientists at Gladstone Institutes showed that a cell therapy derived from stem cells can restore normal patterns of brain activity after a stroke. Most treatments turn effective only after ... This ...

In the new study, Paz and her collaborators tested a stem cell therapy under development by SanBio. One month after rats had a stroke ... restoring balance in neural networks.

Learn More A new neural-network architecture developed by researchers at Google might solve one of the great challenges for large language models (LLMs): extending their memory at inference time ...

Cell therapy developers, especially early-stage companies, often face significant challenges scaling their manufacturing processes, requiring extensive investment in developing their own methods ...

Cabaletta Bio is getting set to launch a clinical trial testing its cell therapy resecabtagene autoleucel (rese-cel) in people with relapsing and progressive forms of multiple sclerosis (MS).